BioCentury
ARTICLE | Distillery Therapeutics

Cardiovascular

January 23, 2019 12:07 AM UTC

Patient sample studies suggest CRISPR-mediated editing of the B isoform of LAMP2 could help treat Danon disease, a cardiomyopathy caused by a loss-of-function LAMP2 point mutations. In cardiomyocytes ...